Table 3 Proportion of WHO global priority AMR pathogens causing bloodstream infections
Priority AMR pathogens* | Year 2019 | Year 2020 | P values | Non COVID-19 cases | COVID-19 cases** | P values |
|---|---|---|---|---|---|---|
Carbapenem resistant Acinetobacter spp. | 46% (48/105) | 48.7% (77/158) | 0.56 | 48.2% (123/255) | 25% (2/8) | 0.29 |
Carbapenem resistant P. aeruginosa | 27% (17/64) | 24.2% (24/99) | 0.74 | 26% (41/158) | 0% (0/5) | 0.33 |
Carbapenem resistant *** K. pneumoniae | 34% (75/218) | 38% (85/224) | 0.44 | 35.9% (155/432) | 50% (5/10) | 0.51 |
3rd Cephalosporin resistant *** K. pneumoniae | 85.3% (186/218) | 82.5% (185/224) | 0.43 | 83.8% (362/432) | 90% (9/10) | > 0.99 |
Carbapenem resistant *** E. coli | 16.3% (21/129) | 10.8% (13/120) | 0.21 | 13% (31/240) | 34% (3/9) | 0.11 |
3rd Cephalosporin resistant *** E. coli | 76% (98/129) | 74.2% (89/120) | 0.74 | 75% (180/240) | 77.8% (7/9) | > 0.99 |
Vancomycin resistant E. faecium | 0% (0/7) | 20% (1/5) | 0.42 | 8.3% (1/12) | 0% (0/0) | Â |
Methicillin resistant S. aureus | 3.4% (3/88) | 9.2% (12/131) | 0.11 | 6.9% (15/216) | 0% (0/3) | > 0.99 |
Fluoroquinolone resistant Salmonella spp. | 17.9% (5/28) | 5.9% (1/17) | 0.38 | 13.3% (6/45) | 0% (0/0) | > 0.99 |
Fluoroquinolone resistant Shigella spp. | 100% (1/1) | 0% (0/0) | Â | 100% (1/1) | 0% (0/0) | Â |
Penicillin resistant S. pneumoniae | 50% (1/2) | 0% (0/1) | > 0.99 | 50% (1/2) | 0% (0/1) | > 0.99 |
Overall**** | 55.9% (359/642) | 51.5% (389/755) | 0.10 | 53.6% (730/1361) | 50% (18/36) | 0.67 |